Historical record - last NADAC publication: 10/19/2017
Product Information
NEUPOGEN 480 MCG/0.8 ML SYR is a brand product labeled by Amgen Inc., priced at $636.0120 per ML under NDC 55513020910. Its NADAC has been published 228 times since Nov 28, 2013.
Strength
480 ug/.8mL
Manufacturer
Amgen Inc.NDC
55513020910
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
10/19/2017
Active Ingredients
FILGRASTIMApproval Type
Biologic (BLA)
FDA Application
BLA103353On Market Since
10/2/2000
Pharmacological Classes
Price Statistics
The NADAC for NEUPOGEN 480 MCG/0.8 ML SYR has been published 228 times since Nov 28, 2013, and over the history we have for it it has risen 6.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $636.0120 per ML |
|---|---|
| All-time high | $636.0120 (Oct 10, 2018) |
| All-time low | $594.0918 (Nov 19, 2014) |
| Median price | $612.0482 |
| Average price | $613.7327 |
| Largest weekly change | +2.9% (Oct 25, 2017) |
| Weeks tracked | 228 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Filgrastim market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of NEUPOGEN 480 MCG/0.8 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for NEUPOGEN 480 MCG/0.8 ML SYR, manufactured by Amgen Inc., is $636.0120 per ML (NDC 55513020910), effective Oct 10, 2018.
How has the price of NEUPOGEN 480 MCG/0.8 ML SYR changed over time?
Over the history we have for it, the NADAC for NEUPOGEN 480 MCG/0.8 ML SYR has risen 6.9%. It has been tracked across 228 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEUPOGEN 480 MCG/0.8 ML SYR?
Since Nov 28, 2013, the NADAC for NEUPOGEN 480 MCG/0.8 ML SYR has ranged from a low of $594.0918 (Nov 19, 2014) to a high of $636.0120 (Oct 10, 2018), with a median of $612.0482 per ML.
Are there cheaper alternatives to NEUPOGEN 480 MCG/0.8 ML SYR?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NEUPOGEN 480 MCG/0.8 ML SYR, so no direct lower-cost alternative is listed.
Who manufactures NEUPOGEN 480 MCG/0.8 ML SYR?
NEUPOGEN 480 MCG/0.8 ML SYR (NDC 55513020910) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification